Share your groundbreaking research with us at #ADARRC2024! Whether you're exploring new frontiers or presenting innovative solutions, we want to hear from you. Submit your abstract today and be part of the conversation shaping the future of #Rheumatology. #CallForAbstracts #Research #Innovation

Question of the week: Which one of the following first-line therapies should be provided after pericardiocentesis in a 20-year-old man presenting with a first episode of a new large pericardial effusion, symptoms of acute pericarditis, an elevated erythrocyte sedimentation rate, and no risk factors for tuberculosis? https://rb.gy/1ivzad

ADARRC wishes you and your loved ones a joyful, happy, and blessed Eid! 🌙

ADARRC wishes you and your loved ones a blessed Ramadan 🌙

Clinical Question: Does the monoclonal antibody sarilumab facilitate the tapering of glucocorticoid therapy in patients with polymyalgia rheumatica? Bottom Line: Giving patients with PMR sarilumab twice monthly for 1 year allows an accelerated tapering regimen that greatly reduces the cumulative steroid dose and increases the likelihood of remission (which was low in both groups). Neutropenia, diarrhea, and arthralgia were common adverse effects. The annual drug cost is estimated to be $18,400. The cost per additional sustained response is more than $90,000, and it is unclear what the value is of the lower cumulative dose of prednisone. Reference: https://bit.ly/49hHs5k

May the blessings and prosperity of the coming year brighten the path of you and your loved ones. #HappyNewYear from ADARRC!

Relive the Best of ADARRC 2023🌟 Thank you for participating in the 13th edition of ADARRC. Your enthusiasm and dedication made this event a great success. We can't wait to see you next year! #ADARRC2023 #MedicalEducation #SeeYouNextYear

Thank you for joining us on this incredible journey through ADARRC Main Course Day 2. Until we meet again! #ADARRC2023 #Farewell #SeeYouSoon

Join us for a recap of the 1st day of the Main Session AT ADARRC 2023! Stay tuned for key insights and memorable moments! #ADARRC2023 #MainSessionHighlights #RheumatologyConference